Ignite Creation Date:
2024-05-06 @ 2:36 PM
Last Modification Date:
2024-10-26 @ 1:33 PM
Study NCT ID:
NCT04362072
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-06-27
First Post:
2020-04-22
Brief Title:
Study of Lorlatinib In People With ALK-positive Non-small Cell Lung Cancer
Sponsor:
Pfizer
Organization:
Pfizer
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-09-29
Start Date Type:
ACTUAL
Primary Completion Date:
2024-05-29
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-08-16
Completion Date Type:
ESTIMATED
First Submit Date:
2020-04-22
First Submit QC Date:
April 22 2020
Study First Post Date:
2020-04-24
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-06-25
Last Update Post Date:
2024-06-27
Last Update Post Date Type:
ACTUAL